OT
This company develops synthetic cyclic peptides based on theta-defensins to treat inflammatory, autoimmune, and infectious diseases. Their technology aims to overcome drug resistance and induce remission in conditions like rheumatoid arthritis.
Founded 2022300+ followers
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops synthetic cyclic peptides based on theta-defensins to treat inflammatory, autoimmune, and infectious diseases. Their technology aims to overcome drug resistance and induce remission in conditions like rheumatoid arthritis.